J Clin Microbiol 2010,48(5):1683–1689. 10.1128/JCM.01947-09286390420335420CrossRefPubMedCentralPubMed 26. Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K, Rüsch-Gerdes S, Niemann S: Sorafenib molecular weight Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob Agents Chemother 2009,53(8):3353–3356. 10.1128/AAC.00050-09271564519470506CrossRefPubMedCentralPubMed Peptide 17 27. Kiet VS, Lan NTN, An DD, Dung NH, Hoa DV, Chau NV, Chinh NT, Farrar J, Caws M: Evaluation of the MTBDRsl test for detection of second-line-drug
resistance in Mycobacterium tuberculosis XAV-939 supplier . J Clin Microbiol 2010,48(8):2934–2939. 10.1128/JCM.00201-10291659820573868CrossRefPubMedCentralPubMed 28. Sirgel FA, Tait
M, Warren RM, Streicher EM, Böttger EC, Van Helden PD, Gey Van Pittius NC, Coetzee G, Hoosain EY, Chabula-Nxiweni M, Hayes C, Victor TC, Trollip A: Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis . Microb Drug Resist 2012 2012,18(2):193–197.CrossRef 29. Suzuki Y, Katsukawa C, Tamaru A, Abe C, Makino M, Mizuguchi Y, Taniguchi H: Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 1998,36(5):1220–1225. 1048039574680CrossRefPubMedCentralPubMed 30. Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC: Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One 2012,7(3):e33275. 10.1371/journal.pone.0033275331557222479378CrossRefPubMedCentralPubMed 31. Jugheli L, Bzekalava N, Rijk PD, Fissette K, Portaels F, Rigouts L: High level of cross-resistance between kanamycin, amikacin and capreomycin among Mycobacterium tuberculosis isolates
from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother 2009,53(12):5064–5068. 10.1128/AAC.00851-09278633719752274CrossRefPubMedCentralPubMed 32. Krüüner A, Jureen P, Levina K, Ghebremichael from S, Hoffner S: Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis . Antimicrob Agents Chemother 2003,47(9):2971–2973. 10.1128/AAC.47.9.2971-2973.200318259912937004CrossRefPubMedCentralPubMed 33. Chen W, Biswas T, Porter VR, Tsodikov OV, Garneau-Tsodikova S: Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB. Proc Natl Acad Sci U S A 2011,108(24):9804–9808. 10.1073/pnas.1105379108311639021628583CrossRefPubMedCentralPubMed 34.